Clinical Trial Update: A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for TST001 in advanced or metastatic solid tumors (Phase 1/2); the study is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer
• Pancreatic Cancer

Drugs mentioned

• TST001

Snippet

Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. | Conditions: Advanced Cancer, Gastric Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING